Ocular drug delivery system designed to treat eye locally, whereas the conventional method of drug delivery is less effective due to the presence of various barriers.

The global market for Ocular Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ocular Drug Delivery System by region & country, by Type, and by Application.

The Ocular Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery System.

Market Segmentation

Scope of Ocular Drug Delivery System - Market Report

Report Metric	Details
Report Name	Ocular Drug Delivery System - Market
CAGR	5%
Segment by Type:	Implantable Ocular Drug Delivery Systems Particulate Drug Delivery Systems
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ocular Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ocular Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ocular Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Ocular Drug Delivery System - Market report?

Ans: The main players in the Ocular Drug Delivery System - Market are Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical

What are the Application segmentation covered in the Ocular Drug Delivery System - Market report?

Ans: The Applications covered in the Ocular Drug Delivery System - Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Ocular Drug Delivery System - Market report?

Ans: The Types covered in the Ocular Drug Delivery System - Market report are Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems

1 Market Overview

1.1 Ocular Drug Delivery System Product Introduction

1.2 Global Ocular Drug Delivery System Market Size Forecast

1.2.1 Global Ocular Drug Delivery System Sales Value (2019-2030)

1.2.2 Global Ocular Drug Delivery System Sales Volume (2019-2030)

1.2.3 Global Ocular Drug Delivery System Sales Price (2019-2030)

1.3 Ocular Drug Delivery System Market Trends & Drivers

1.3.1 Ocular Drug Delivery System Industry Trends

1.3.2 Ocular Drug Delivery System Market Drivers & Opportunity

1.3.3 Ocular Drug Delivery System Market Challenges

1.3.4 Ocular Drug Delivery System Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Ocular Drug Delivery System Players Revenue Ranking (2023)

2.2 Global Ocular Drug Delivery System Revenue by Company (2019-2024)

2.3 Global Ocular Drug Delivery System Players Sales Volume Ranking (2023)

2.4 Global Ocular Drug Delivery System Sales Volume by Company Players (2019-2024)

2.5 Global Ocular Drug Delivery System Average Price by Company (2019-2024)

2.6 Key Manufacturers Ocular Drug Delivery System Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Ocular Drug Delivery System Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Ocular Drug Delivery System

2.9 Ocular Drug Delivery System Market Competitive Analysis

2.9.1 Ocular Drug Delivery System Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Ocular Drug Delivery System Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery System as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Implantable Ocular Drug Delivery Systems

3.1.2 Particulate Drug Delivery Systems

3.2 Global Ocular Drug Delivery System Sales Value by Type

3.2.1 Global Ocular Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Ocular Drug Delivery System Sales Value, by Type (2019-2030)

3.2.3 Global Ocular Drug Delivery System Sales Value, by Type (%) (2019-2030)

3.3 Global Ocular Drug Delivery System Sales Volume by Type

3.3.1 Global Ocular Drug Delivery System Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Ocular Drug Delivery System Sales Volume, by Type (2019-2030)

3.3.3 Global Ocular Drug Delivery System Sales Volume, by Type (%) (2019-2030)

3.4 Global Ocular Drug Delivery System Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Ambulatory Surgical Centers

4.2 Global Ocular Drug Delivery System Sales Value by Application

4.2.1 Global Ocular Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Ocular Drug Delivery System Sales Value, by Application (2019-2030)

4.2.3 Global Ocular Drug Delivery System Sales Value, by Application (%) (2019-2030)

4.3 Global Ocular Drug Delivery System Sales Volume by Application

4.3.1 Global Ocular Drug Delivery System Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Ocular Drug Delivery System Sales Volume, by Application (2019-2030)

4.3.3 Global Ocular Drug Delivery System Sales Volume, by Application (%) (2019-2030)

4.4 Global Ocular Drug Delivery System Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Ocular Drug Delivery System Sales Value by Region

5.1.1 Global Ocular Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Ocular Drug Delivery System Sales Value by Region (2019-2024)

5.1.3 Global Ocular Drug Delivery System Sales Value by Region (2025-2030)

5.1.4 Global Ocular Drug Delivery System Sales Value by Region (%), (2019-2030)

5.2 Global Ocular Drug Delivery System Sales Volume by Region

5.2.1 Global Ocular Drug Delivery System Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Ocular Drug Delivery System Sales Volume by Region (2019-2024)

5.2.3 Global Ocular Drug Delivery System Sales Volume by Region (2025-2030)

5.2.4 Global Ocular Drug Delivery System Sales Volume by Region (%), (2019-2030)

5.3 Global Ocular Drug Delivery System Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Ocular Drug Delivery System Sales Value, 2019-2030

5.4.2 North America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Ocular Drug Delivery System Sales Value, 2019-2030

5.5.2 Europe Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Ocular Drug Delivery System Sales Value, 2019-2030

5.6.2 Asia Pacific Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Ocular Drug Delivery System Sales Value, 2019-2030

5.7.2 South America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Ocular Drug Delivery System Sales Value, 2019-2030

5.8.2 Middle East & Africa Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Ocular Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Ocular Drug Delivery System Sales Value

6.2.1 Key Countries/Regions Ocular Drug Delivery System Sales Value, 2019-2030

6.2.2 Key Countries/Regions Ocular Drug Delivery System Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Ocular Drug Delivery System Sales Value, 2019-2030

6.3.2 United States Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Ocular Drug Delivery System Sales Value, 2019-2030

6.4.2 Europe Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Ocular Drug Delivery System Sales Value, 2019-2030

6.5.2 China Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.5.3 China Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Ocular Drug Delivery System Sales Value, 2019-2030

6.6.2 Japan Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Ocular Drug Delivery System Sales Value, 2019-2030

6.7.2 South Korea Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Ocular Drug Delivery System Sales Value, 2019-2030

6.8.2 Southeast Asia Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Ocular Drug Delivery System Sales Value, 2019-2030

6.9.2 India Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.9.3 India Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ocular Therapeutix

7.1.1 Ocular Therapeutix Company Information

7.1.2 Ocular Therapeutix Introduction and Business Overview

7.1.3 Ocular Therapeutix Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Ocular Therapeutix Ocular Drug Delivery System Product Offerings

7.1.5 Ocular Therapeutix Recent Development

7.2 Alimera Sciences

7.2.1 Alimera Sciences Company Information

7.2.2 Alimera Sciences Introduction and Business Overview

7.2.3 Alimera Sciences Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Alimera Sciences Ocular Drug Delivery System Product Offerings

7.2.5 Alimera Sciences Recent Development

7.3 Allergan

7.3.1 Allergan Company Information

7.3.2 Allergan Introduction and Business Overview

7.3.3 Allergan Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Allergan Ocular Drug Delivery System Product Offerings

7.3.5 Allergan Recent Development

7.4 Graybug Vision

7.4.1 Graybug Vision Company Information

7.4.2 Graybug Vision Introduction and Business Overview

7.4.3 Graybug Vision Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Graybug Vision Ocular Drug Delivery System Product Offerings

7.4.5 Graybug Vision Recent Development

7.5 Bausch Health

7.5.1 Bausch Health Company Information

7.5.2 Bausch Health Introduction and Business Overview

7.5.3 Bausch Health Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bausch Health Ocular Drug Delivery System Product Offerings

7.5.5 Bausch Health Recent Development

7.6 EyePoint Pharmaceuticals

7.6.1 EyePoint Pharmaceuticals Company Information

7.6.2 EyePoint Pharmaceuticals Introduction and Business Overview

7.6.3 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.6.4 EyePoint Pharmaceuticals Ocular Drug Delivery System Product Offerings

7.6.5 EyePoint Pharmaceuticals Recent Development

7.7 Santen Pharmaceutical

7.7.1 Santen Pharmaceutical Company Information

7.7.2 Santen Pharmaceutical Introduction and Business Overview

7.7.3 Santen Pharmaceutical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Santen Pharmaceutical Ocular Drug Delivery System Product Offerings

7.7.5 Santen Pharmaceutical Recent Development

7.8 Taiwan Liposome

7.8.1 Taiwan Liposome Company Information

7.8.2 Taiwan Liposome Introduction and Business Overview

7.8.3 Taiwan Liposome Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Taiwan Liposome Ocular Drug Delivery System Product Offerings

7.8.5 Taiwan Liposome Recent Development

7.9 Envisia Therapeutics

7.9.1 Envisia Therapeutics Company Information

7.9.2 Envisia Therapeutics Introduction and Business Overview

7.9.3 Envisia Therapeutics Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Envisia Therapeutics Ocular Drug Delivery System Product Offerings

7.9.5 Envisia Therapeutics Recent Development

7.10 Clearside Biomedical

7.10.1 Clearside Biomedical Company Information

7.10.2 Clearside Biomedical Introduction and Business Overview

7.10.3 Clearside Biomedical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Clearside Biomedical Ocular Drug Delivery System Product Offerings

7.10.5 Clearside Biomedical Recent Development

8 Industry Chain Analysis

8.1 Ocular Drug Delivery System Industrial Chain

8.2 Ocular Drug Delivery System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Ocular Drug Delivery System Sales Model

8.5.2 Sales Channel

8.5.3 Ocular Drug Delivery System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Eyepoint Pharmaceuticals

Santen Pharmaceutical

Taiwan Liposome

Envisia Therapeutics

Clearside Biomedical

List of Tables

Table 1. Ocular Drug Delivery System Market Trends

Table 2. Ocular Drug Delivery System Market Drivers & Opportunity

Table 3. Ocular Drug Delivery System Market Challenges

Table 4. Ocular Drug Delivery System Market Restraints

Table 5. Global Ocular Drug Delivery System Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Ocular Drug Delivery System Revenue Market Share by Company (2019-2024)

Table 7. Global Ocular Drug Delivery System Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Ocular Drug Delivery System Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Ocular Drug Delivery System Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Ocular Drug Delivery System Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Ocular Drug Delivery System Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Ocular Drug Delivery System

Table 13. Global Ocular Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery System as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Ocular Drug Delivery System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Ocular Drug Delivery System Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Ocular Drug Delivery System Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Ocular Drug Delivery System Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Ocular Drug Delivery System Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Ocular Drug Delivery System Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Ocular Drug Delivery System Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Ocular Drug Delivery System Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Ocular Drug Delivery System Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Ocular Drug Delivery System Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Ocular Drug Delivery System Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Ocular Drug Delivery System Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Ocular Drug Delivery System Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Ocular Drug Delivery System Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Ocular Drug Delivery System Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Ocular Drug Delivery System Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Ocular Drug Delivery System Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Ocular Drug Delivery System Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Ocular Drug Delivery System Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Ocular Drug Delivery System Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Ocular Drug Delivery System Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Ocular Drug Delivery System Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Ocular Drug Delivery System Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Ocular Drug Delivery System Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Ocular Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Ocular Drug Delivery System Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Ocular Drug Delivery System Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Ocular Drug Delivery System Sales Value by Region (2019-2024) & (%)

Table 44. Global Ocular Drug Delivery System Sales Value by Region (2025-2030) & (%)

Table 45. Global Ocular Drug Delivery System Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Ocular Drug Delivery System Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Ocular Drug Delivery System Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Ocular Drug Delivery System Sales Volume by Region (2019-2024) & (%)

Table 49. Global Ocular Drug Delivery System Sales Volume by Region (2025-2030) & (%)

Table 50. Global Ocular Drug Delivery System Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Ocular Drug Delivery System Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Ocular Drug Delivery System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Ocular Drug Delivery System Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Ocular Drug Delivery System Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Ocular Drug Delivery System Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Ocular Drug Delivery System Sales Volume, (2025-2030) & (K Units)

Table 57. Ocular Therapeutix Company Information

Table 58. Ocular Therapeutix Introduction and Business Overview

Table 59. Ocular Therapeutix Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Ocular Therapeutix Ocular Drug Delivery System Product Offerings

Table 61. Ocular Therapeutix Recent Development

Table 62. Alimera Sciences Company Information

Table 63. Alimera Sciences Introduction and Business Overview

Table 64. Alimera Sciences Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Alimera Sciences Ocular Drug Delivery System Product Offerings

Table 66. Alimera Sciences Recent Development

Table 67. Allergan Company Information

Table 68. Allergan Introduction and Business Overview

Table 69. Allergan Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Allergan Ocular Drug Delivery System Product Offerings

Table 71. Allergan Recent Development

Table 72. Graybug Vision Company Information

Table 73. Graybug Vision Introduction and Business Overview

Table 74. Graybug Vision Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Graybug Vision Ocular Drug Delivery System Product Offerings

Table 76. Graybug Vision Recent Development

Table 77. Bausch Health Company Information

Table 78. Bausch Health Introduction and Business Overview

Table 79. Bausch Health Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Bausch Health Ocular Drug Delivery System Product Offerings

Table 81. Bausch Health Recent Development

Table 82. EyePoint Pharmaceuticals Company Information

Table 83. EyePoint Pharmaceuticals Introduction and Business Overview

Table 84. EyePoint Pharmaceuticals Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. EyePoint Pharmaceuticals Ocular Drug Delivery System Product Offerings

Table 86. EyePoint Pharmaceuticals Recent Development

Table 87. Santen Pharmaceutical Company Information

Table 88. Santen Pharmaceutical Introduction and Business Overview

Table 89. Santen Pharmaceutical Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Santen Pharmaceutical Ocular Drug Delivery System Product Offerings

Table 91. Santen Pharmaceutical Recent Development

Table 92. Taiwan Liposome Company Information

Table 93. Taiwan Liposome Introduction and Business Overview

Table 94. Taiwan Liposome Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Taiwan Liposome Ocular Drug Delivery System Product Offerings

Table 96. Taiwan Liposome Recent Development

Table 97. Envisia Therapeutics Company Information

Table 98. Envisia Therapeutics Introduction and Business Overview

Table 99. Envisia Therapeutics Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Envisia Therapeutics Ocular Drug Delivery System Product Offerings

Table 101. Envisia Therapeutics Recent Development

Table 102. Clearside Biomedical Company Information

Table 103. Clearside Biomedical Introduction and Business Overview

Table 104. Clearside Biomedical Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Clearside Biomedical Ocular Drug Delivery System Product Offerings

Table 106. Clearside Biomedical Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Ocular Drug Delivery System Downstream Customers

Table 110. Ocular Drug Delivery System Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Ocular Drug Delivery System Product Picture

Figure 2. Global Ocular Drug Delivery System Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Ocular Drug Delivery System Sales Volume (2019-2030) & (K Units)

Figure 5. Global Ocular Drug Delivery System Sales Price (2019-2030) & (US$/Unit)

Figure 6. Ocular Drug Delivery System Report Years Considered

Figure 7. Global Ocular Drug Delivery System Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Ocular Drug Delivery System Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ocular Drug Delivery System Revenue in 2023

Figure 10. Ocular Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Implantable Ocular Drug Delivery Systems Picture

Figure 12. Particulate Drug Delivery Systems Picture

Figure 13. Global Ocular Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Ocular Drug Delivery System Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Ocular Drug Delivery System Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Ocular Drug Delivery System Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Ocular Drug Delivery System Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospitals

Figure 19. Product Picture of Clinics

Figure 20. Product Picture of Ambulatory Surgical Centers

Figure 21. Global Ocular Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Ocular Drug Delivery System Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Ocular Drug Delivery System Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Ocular Drug Delivery System Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Ocular Drug Delivery System Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Ocular Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Ocular Drug Delivery System Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Ocular Drug Delivery System Sales Volume (%), (2019-2030)

Figure 38. United States Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 44. China Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 46. China Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 56. India Ocular Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 58. India Ocular Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 59. Ocular Drug Delivery System Industrial Chain

Figure 60. Ocular Drug Delivery System Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions